Last reviewed · How we verify

Silver nanoparticles mouthwash

Can Tho University of Medicine and Pharmacy · Phase 3 active Small molecule

Silver nanoparticles in mouthwash exert antimicrobial effects by disrupting bacterial cell membranes and inhibiting microbial growth in the oral cavity.

Silver nanoparticles in mouthwash exert antimicrobial effects by disrupting bacterial cell membranes and inhibiting microbial growth in the oral cavity. Used for Oral antimicrobial therapy for dental plaque and gingivitis prevention, Oral cavity infection management.

At a glance

Generic nameSilver nanoparticles mouthwash
Also known asAgNPs mouthwash
SponsorCan Tho University of Medicine and Pharmacy
Drug classAntimicrobial nanoparticle
ModalitySmall molecule
Therapeutic areaDentistry / Oral Health
PhasePhase 3

Mechanism of action

Silver nanoparticles are known to have broad-spectrum antimicrobial properties through multiple mechanisms including direct contact with bacterial cell walls, generation of reactive oxygen species, and interference with bacterial metabolism. When formulated as a mouthwash, they target oral pathogens responsible for dental plaque, gingivitis, and other oral infections. The nanoparticle formulation allows for enhanced bioavailability and contact with oral tissues.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: